key: cord-0961082-23i67q1k authors: Sur, Subhayan; Khatun, Mousumi; Steele, Robert; Isbell, T. Scott; Ray, Ranjit; Ray, Ratna B. title: Exosomes from COVID-19 patients carry tenascin-C and fibrinogen-β in triggering inflammatory signals in distant organ cells date: 2021-02-09 journal: bioRxiv DOI: 10.1101/2021.02.08.430369 sha: 1528b1d67f27183ce225533fde319556f1156043 doc_id: 961082 cord_uid: 23i67q1k SARS-CoV-2 infection causes cytokine storm and overshoot immunity in humans; however, it remains to be determined whether genetic material of SARS-CoV-2 and/or virus induced soluble mediators from lung epithelial cells as natural host are carried out by macrophages or other vehicles at distant organs causing tissue damage. We speculated that exosomes as extracellular vesicles are secreted from SARS-CoV-2 infected cells may transport messages to other cells of distant organs leading to pathogenic consequences. For this, we took an unbiased proteomic approach for analyses of exosomes isolated from plasma of healthy volunteers and SARS-CoV-2 infected patients. Our results revealed that tenascin-C (TNC) and fibrinogen-β (FGB) are highly abundant in exosomes from SARS-CoV-2 infected patient’s plasma as compared to that of healthy normal controls. Since TNC and FGB stimulate pro-inflammatory cytokines via NF-κB pathway, we examined the status of TNF-α, IL-6 and CCL5 expression upon exposure of hepatocytes to exosomes from COVID-19 patients and observed significant increase when compared with that from healthy subjects. Together, our results demonstrated that soluble mediators, like TNC and FGB, are transported through plasma exosomes in SARS-CoV-2 infected patients and trigger pro-inflammatory cytokine expression in cells of distant organs in COVID-19 patients. Importance Exosomes play an important role in intercellular communication by inducing physiological changes in recipient cells by transferring bioactive proteins. Little is known about exosomes from SARS-CoV-2 infected cells and their role in pathogenesis. Here, we have carefully examined and analyzed this aspect of SARS-CoV-2 infection. Our results uncovered the potential mechanisms by which SARS-CoV-2 communicates with other cells of distant organs and promotes pathogenesis. We expect to detect whether other factors are modulated in the presence of COVID-19 exosomes. Our exosomes related proteomic experiments prioritize after initial verification to further examine their role in SARS-CoV-2 associated other pathogenic mechanisms to target for therapeutic modalities. was verified from the exosome preparations by Western blot analysis as described previously (10, 11) and 103 the results from a representative blot is shown (Figure 1, panel B) . Exosome depleted serum (Invitrogen) 104 was used a negative control and as expected, did not exhibit the presence or cross-reactivity for CD63 or 105 TSG101 proteins. N1 and N2 of SARS-CoV-2 RNAs were undetected in exosome preparation from 106 patients or healthy subject controls using a CDC recommended PCR kit. 107 108 Exosomes from plasma of COVID-19 patients harbor tenascin-C and fibrinogen-β. Little is 109 known about the proteome profile of the exosomes from COVID-19 patients. Using unbiased 110 proteomic approach, the mass spectrometry analysis identified 1,637 proteins. We shortlisted 163 111 proteins having more than five spectra counts and at least twofold changes as compared to 112 plasma exosomes from healthy volunteers (Figure 2, panels A and B) . Tenascin-C (TNC) and hepatocytes in vitro were used as a model cell line and exposed to exosomes from COVID-19 135 patients or from healthy controls. A significant upregulation of tumor necrosis factor-α (TNF-α), 136 interleukin-6 (IL-6) and C-C motif chemokine ligand 5 (CCL5) were observed from exposure of 137 immortalized human hepatocytes (IHH) to exosomes isolated from COVID19 patient plasma, as 138 compared to exosomes from healthy normal plasma (Figure 4, panel A) . Similar results were 139 7 noted from COVID-19 plasma exosomes when exposed to a different cell line with hepatocyte 140 origin (Huh7). Pearson correlation analysis among expressions of the TNF-α, IL-6 and CCL5 in 141 the hepatocytes exposed with patient exosomes. A significant positive correlation (P= 0.001, r= 142 0.66) was seen between TNF-α and CCL5 expression from hepatocytes (Figure 4, panel B) . 143 These results demonstrated that COVID-19 plasma exosomes trigger strong pro-inflammatory 144 cytokine production in hepatocytes. (FBS) and 1% penicillin/streptomycin at 37°C in a 5% CO 2 atmosphere. IHH and Huh7 cells 229 were seeded into 6-well plate at a density of 3x10 5 cells/well and exposed to equal concentration 230 of exosomes for 48h. Cells were harvested for RNA analyses. Coronavirus biology and 275 replication: implications for SARS-CoV-2 Presence of SARS-CoV-2 RNA in 279 the Cornea of Viremic Patients With COVID-19 Blood molecular markers 284 associated with COVID-19 immunopathology and multi-organ damage Extrapulmonary manifestations of COVID-19 SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of 293 angiotensin II receptor signaling in epithelial cells Extracellular vesicles: Novel mediator for cell to cell 295 communications in liver pathogenesis vesicle fibrinogen induces encephalitogenic CD8+ T cells in a mouse model of multiple 320 sclerosis Coagulopathy of Coronavirus 322 Disease Activators and target genes of Rel/NF-kappaB transcription factors CoV-2 detection, viral load and infectivity over the course of an infection Mechanisms Underlying Hepatitis C Virus-Associated Hepatic 336 Exosomal Transmission of MicroRNA from HCV 338 Replicating Cells Stimulates Transdifferentiation in Hepatic Stellate Cells Omics-Driven Systems Interrogation of Metabolic 343 Dysregulation in COVID-19 Pathogenesis The role of exosomes in tumor immunity Fibrinogen 347 synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 348 (FGF-2) FGB and 350 FGG derived from plasma exosomes as potential biomarkers to distinguish benign from 351 malignant pulmonary nodules Increased liver-specific 353 proteins in circulating extracellular vesicles as potential biomarkers for drug-and 354 alcohol-induced liver injury Extracellular vesicles as potential 356 biomarkers for alcohol-and drug-induced liver injury and their therapeutic applications Chlorogenic acid inhibits cholestatic liver injury induced by alpha-360 naphthylisothiocyanate: involvement of STAT3 and NFkappaB signalling regulation Serum-Derived Extracellular Vesicles from African Swine Fever Virus-Infected Pigs Selectively Recruit Viral and Porcine 365 Proteins IL-6: Relevance 367 for immunopathology of SARS-CoV-2 An inflammatory cytokine signature helps predict 373 COVID-19 severity and death Sacha 377 JB. 2020. Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune 378 Homeostasis and Reduces Plasma Viral Load in Critical COVID-19. medRxiv 379 An aberrant STAT 381 pathway is central to COVID-19 by densitometry analysis using ImageJ software (right panel) are shown (n=8 normal and n=20 411 COVID-19 samples). TSG101, an exosomal marker protein, was used for normalization of each 412 sample. (**, p<0.01; ***, p<0.001). C: String analysis network module represents functional 413 association of TNC and FGB with TLR4/NF-kB signaling. Each node represents all the proteins 414 produced by a single protein coding gene locus. Colored node represents query proteins and first 415 shell of interactions. Filled node shows 3D structure (known or predicted). Edges represent